RecallHawk

XYZAL ALLERGY 24HR (LEVOCETIRIZINE DIHYDROCHLORIDE)

CHATTEM SANOFI

Summary

FDA approved XYZAL ALLERGY 24HR (LEVOCETIRIZINE DIHYDROCHLORIDE) by CHATTEM SANOFI. NDA (New Drug) approval (Labeling) on 2026-05-20. TABLET, ORAL.

Details

Source

Drug Approval

External ID

NDA209089-10

Action Date

2026-05-20

Status

Approved

Category

drug

Product Code

NDA (New Drug)

Product Description

XYZAL ALLERGY 24HR (generic: LEVOCETIRIZINE DIHYDROCHLORIDE), TABLET, ORAL. Application: NDA209089

Context & Analysis

CHATTEM SANOFI has 5 FDA actions in our database.

Frequently Asked Questions

How often does CHATTEM SANOFI have FDA actions?

CHATTEM SANOFI has 5 FDA actions in our database, including 0 recalls and 0 device clearances.

Where can I find the official FDA record?

The official record is available on FDA.gov. Search for "NDA209089-10" on FDA.gov for the full record. You can also use the openFDA API to query this record programmatically.

Want to know the moment something like this happens?

Get alerts for drug

Related Actions